FDA Approves Pfizer’s Covid-19 Vaccine. Will This Save The Economy?
December 11, 2020 8:19 PM Kelly Anne Smith - Forbes Advisor
Posted:
Updated:
December 13, 2020 9:00 AM
In a widely expected move, the Federal Drug Administration (FDA) has granted Emergency Use Authorization to Pfizer’s Covid-19 vaccine.
The approval comes after the FDA’s advisory panel made a recommendation to authorize the vaccine on Thursday and almost 11 months after a national public health emergency was declared in the United States. The nation has severely struggled with Covid-19 since then, with over 15 million confirmed cases and over 294,000 deaths, according to the most recent data. The U.S. economy has also endured considerable damage and slipped into a recession; as many as 20.5 million Americans lost their jobs during the peak of the first wave in April.
In a widely expected move, the Federal Drug Administration (FDA) has granted Emergency Use Authorization to Pfizerâs Covid-19 vaccine.
The approval comes after the FDAâs advisory panel made a recommendation to authorize the vaccine on Thursday and almost 11 months after a national public health emergency was declared in the United States. The nation has severely struggled with Covid-19 since then, with over 15 million confirmed cases and over 294,000 deaths, according to the most recent data. The U.S. economy has also endured considerable damage and slipped into a recession; as many as 20.5 million Americans lost their jobs during the peak of the first wave in April.